Verastem, Inc. cash flow to debt ratio of -178.90% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Verastem, Inc.'s free cash flow has decreased 31.21% from $-104.80M last year to $-137.51M, signaling decreasing performance

Verastem, Inc.'s debt to equity ratio is 1.69, which means that the company's assets are unhealthy financed, signaling financial risk.

Verastem, Inc.'s debt has increased relative to shareholder equity from -1.46 last year to 1.69 today, signaling weakened financials

Verastem, Inc. has a net cash position, so leverage is healthy.

Verastem, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Verastem, Inc.'s profit margin has increased (-82.27%) in the last year from -1.31K% to -231.59%, signaling increasing performance

Verastem, Inc.'s short-term assets of $223.41M exceed its short-term liabilities of $72.27M

Verastem, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Verastem, Inc.'s return on equity of -467.49%, is lower than 15.00%, indicating bad performance

Verastem, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Verastem, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Verastem, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Verastem, Inc. has negative free cash flow, indicating cash burn

Verastem, Inc.'s yearly earnings has decreased 60.35% since last year from $-130.64M to $-209.47M, signaling decreasing performance

Verastem, Inc.'s yearly revenue has increased 209.14% since last year from $10.00M to $30.91M, signaling increasing performance

ROIC -118.54% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Verastem, Inc.'s 3-year revenue CAGR of 128.36% is positive, indicating growing revenue over the past 3 years

Verastem, Inc. had revenue growth in 3 out of 5 years, indicating consistent revenue performance

Verastem, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Verastem, Inc. has insufficient data to evaluate this check.

Verastem, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Verastem, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Verastem, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Verastem, Inc. is overvalued relative to its fair value price of -59.29 based on Earnings Fair Value model

Verastem, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Verastem, Inc. has a price-to-book ratio of 13.60x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

Verastem, Inc. has a price-to-sales ratio of 7.77x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue